Research Journal of Pharmaceutical Dosage Form and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

A concise review on analytical profile of chlorthalidone


Affiliations
1 Department of Pharmaceutics, Smt. S. S. Patil College of Pharmacy, Chopda: 425107, Maharashtra,, India
2 Department of Pharmaceutical Chemistry, TSPM’s, Trimurti Institute of Pharmacy, Paldhi (Bk): 425103, Jalgaon, Maharashtra,, India
3 Department of Pharmaceutics, TSPM’s, Trimurti Institute of Pharmacy, Paldhi (Bk): 425103, Jalgaon, Maharashtra,, India
4 4Department of Pharmaceutical Chemistry, H. R. Patel Institute of Pharmaceutical Education and Research, Shirpur: 425405, Dhule, Maharashtra,, India
     

   Subscribe/Renew Journal


Chlorthalidone (CHL) is an anti-hypertensive that reduces active sodium reabsorption and peripheral vascular resistance. Also, it is a diuretic commonly known as a thiazide diuretic. Due to the huge amount of use of CHL in different dosage forms for the management of hypertension, it needs qualitative and quantitative estimation in the pharmaceutical and biological formulation. Therefore, the main objective of this analysis of CHL in the pharmaceutical and biological formulation is in both qualitative and quantitative terms. In this review article, we have summarized UV/Vis Spectroscopy, high-performance liquid chromatography (HPLC), High-performance thin-layer chromatography (HPTLC), Ultra performance liquid chromatography (UPLC), etc. based methods for estimation of chlorthalidone. In addition to that, we have discussed the bioanalytical methods for CHL analysis. In conclusion, this review article will help to research scholars for further method development for drug estimation in pharmaceutical dosage forms and biological fluids.

Keywords

Chlorthalidone, Anti-hypertensive, Analytical methods, High-performance liquid chromatography, Bioanalytical methods.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Gandhi SV, Sanklecha AP. HPLC method development and validation for estimation of chlorthalidone in tablet dosage form. Journal of Drug Delivary and Therapeutics. 2019; 9(4): 53-56.

  • “Drug profile for Chlorthalidone”: http://www.drugbank.ca/drugs/DB00310

  • Kerndt C, Patel J. Chlorthalidone. 2020; https://www.ncbi.nlm.nih.gov/books/NBK553174/.

  • Prabanathan A. Research Work: Development and Validation of Analytical Methods for the Simultaneous Estimation of Telmisartan and Chlorthalidone. http://repository-tnmgrmu.ac.in/id/eprint/2262.

  • US Food and Drug Administration. https://www.fda.gov/.

  • Spooner N. Dried blood spot sampling for quantitative bioanalysis, time for a revolution. Bioanalysis. 2010; 2: 1781.

  • Dadgar D, Kelly MT. Determination of chlorthalidone in human plasma by reversed-phase micellar liquid chromatography. Analyst.1988; 113(8): 1223-1227.

  • Elgawish MS, Mostafa SM, Elshanawane AA. Simple and rapid HPLC method for simultaneous determination of atenolol and chlorthalidone in spiked human plasma. Saudi Pharmaceutical Journal. 2011; 19 (1): 43–49.

  • Belal F, El-Brashy AM, El-Enany N, Tolba MM. Simultaneous determination of celiprolol HCl and chlorthalidone in tablets and biological fluids using high-performance liquid chromatography. Acta Chromatographica. 2012; 24 (2): 185–206.

  • El Gindy A, Sallam S, Abdel Salam RA. HPLC method for the simultaneous determination of atenolol and chlorthalidone in human breast milk. Journal of Separation Science. 2008; 31 (4): 677-682.

  • Giachetti C, Tenconi A, Canali S, Zanolo G. Simultaneous determination of atenolol and chlorthalidone in plasma by highperformance liquid chromatography Application to pharmacokinetic studies in man. Journal of Chromatography B: Biomedical Sciences and Applications. 1997; 698(1-2): 187-194.

  • Nalawade V, Joshi S. Development and validation of LC-MS / MS method for simultaneous determination of azilsartan medoxomil and chlorthalidone from the human plasma. Journal of Pharmaceutical Sciences and Research. 2019; 11 (7): 2533–2537.

  • Campíns-Falcó P, Herráez-Hernández R, Sevtllano-Cabeza A. Simple and sensitive reversed-phase liquid chromatographic assay for analysis of chlorthalidone in urine. Journal of Liquid Chromatography & Related Technologies. 1993; 16 (12): 2571-2581.

  • Herraez-Hernandez R, Campins-Falco P, Sevillano-Cabeza A. Application of column switching in high performance liquid chromatographic analysis of chlorthalidone enantiomers in untreated urine. Journal of Liquid Chromatography and Related Technologies. 1996; 19(3): 403-414.

  • Rosenberg MJ, Lam KK, Dorsey TE. Analysis of chlorthalidone in whole blood by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications. 1986; 375; 438–443.

  • Guelen PJM, Baars AM, Vree TB, Nijkerk AJ, Vermeer JM. Rapid and sensitive determination of chlorthalidone in blood, plasma and urine of man using high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications.1980; 181 (3-4): 497–503.

  • Khuroo A, Mishra S, Singh O, Saxena S, Monif T. Simultaneous determination of atenolol and chlorthalidone by LC–MS–MS in human plasma. Chromatographia. 2008; 68(9): 721-729.

  • Ramakrishna R, kumar Puttrevu S, Bhateria M, Bala V, Sharma VL, Bhatta RS. Simultaneous determination of azilsartan and chlorthalidone in rat and human plasma by liquid chromatographyelectrospray tandem mass spectrometry. Journal of Chromatography B. 2015; 990: 185-197.

  • Salado SC, Vera-Avila LE. On-line solid-phase extraction and highperformance liquid chromatographic determination of chlorthalidone in urine. Journal of Chromatography B: Biomedical Sciences and Applications. 1997; 690 (1-2): 195-202.

  • Shah JV, Patel DP, Shah PA, Sanyal M, Shrivastav PS. Simultaneous quantification of atenolol and chlorthalidone in human plasma by ultra performance liquid chromatography – tandem mass spectrometry. Biomedical Chromatography, 2016; 30 (2): 208–216.

  • Patel B, Jangid AG, Suhagia BN, Desai N. The simultaneous UPLC – MS / MS determination of emerging drug combination; candesartan and chlorthalidone in human plasma and its application. Biomedical Chromatography. 2017; 31 (9): e3946.

  • Niraimathi V, Jerad SA, Kumar SI. UV Spectrophotometric methods for the estimation of chlorthalidone in bulk and oral dosage form. Indo American Journal of Pharmaceutical Sciences. 2013; 3 (9): 7160-7167.

  • Ingle SU, Patil PA, Kulkarni V, Patil SV, Salunke PA, Wagh RS. Development and validation of UV spectrophotometric method for chlorthalidone in bulk and pharmaceutical dosage forms. World Journal of Pharmaceutical Research. 2014; 3(9): 958-63.

  • Patel SN, Hinge MA, Bhanushali VM. Development and validation of a UV spectrophotometric method for the simultaneous determination of cilnidipine and chlorthalidone. Journal of Pharmaceutical Research. 2015; 9 (1): 41-45.

  • Bhanushali VM, Hinge MA, Patel SN. Development and validation of UV spectrophotometric methods for simultaneous determination of Chlorthalidone and Losartan potassium. Journal of Pharmacy Research. 2015; 9: 54-59.

  • Kalyankar GG, Patel J, Bodiwala KB, Lodha SR, Mistry V. Development and validation of first order UV derivative spectroscopy method for simultaneous estimation of cilnidipine and chlorthalidone in their combined tablet dosage form. An International Journal of Pharmaceutical Sciences. 2019; 10(2): 101-111.

  • Sheth A, Shah N. Simultaneous UV spectrophotometric method for simultaneous estimation of olmesartan medoxomil and chlorthalidone in their combined dosage forms. Pharma Science Monitor. 2016; 7 (3).

  • Sawale V, Dhabarde DM, Mahapatra DK. Development and validation of UV spectrophotometric method for simultaneous estimation of olmesartan medoxomil and chlorthalidone in bulk and tablet. Eurasian Journal of Analytical Chemistry. 2017; 12(1): 55-66.

  • AH S, Patel CN, Shah NJ. Article Details UV spectrophotometric method for simultaneous estimation of Chlorthalidone and Nebivolol hydrochloride in their combined dosage forms. Indian Drug. 2016; 53(11): 38-45.

  • Pimple HC, Rane SS, Patil HD, Chaudhari RY, Patil VR. Simultaneous spectrophotometric estimation of atenolol and chlorthalidone in tablet dosage form. Journal of Pharmaceutical and BioSciences. Jan-Mar, 2017; 5 (1): 6-9.

  • Raval HV, Patel DM, Patel CN. Estimation of metoprolol tartrate and chlorthalidone in combined dosage form by UV-spectrophotometric methods. Research Journal of Pharmacy and Technology.2011; 4(7): 1132-1134.

  • Barot D, Pradhan PK, Patel G, Shah S, Parmar HP, Dey S, Upadhyay UM. Simultaneous UV spectrophotometric estimation of olmesartane medoxomil and chlorthalidone in tablet dosage form. The Pharma Innovation, 2014; 3 (10, Part B): 76.

  • Chaudhary BR, Dave JB. Spectrophotometric method development and validation for simultaneous estimation of telmisartan and chlorthalidone in dosage form by second derivative method. Pharma Science Monitor. 2019; 10(3).

  • Padmane SP, Jain ND, Ittadwar AM, Walde SP. A Derivative UV spectrophotometric method for the simultaneous determination of metoprolol succinate and chlorthalidone in combined dose tablet formulation. International Journal of Analytical and Bioanalytical Chemistry. 2014; 4 (1): 33-41.

  • Ebeid WM, Elkady EF, El-Zaher AA, El-Bagary RI, Patonay G. Spectrophotometric and spectrofluorimetric studies on azilsartan medoxomil and chlorthalidone to be utilized in their determination in pharmaceuticals. An Analytical Chemistry Insights. 2014; 9: 33-40.

  • Patel S, Patel D. Simultaneous determination of metoprolol succinate and chlorthalidone by UV spectrophotometric method. Pharmagene. 2013; 1(3): 39-43.

  • Akiful HM, Nivedita G, Prashanth KK, Pradeep K T, Hasan AS, Prakash VD. Simultaneous estimation of atenolol and chlorthalidone as bulk and in tablet dosage form using UV-spectrophotometry. Journal of pharmacy and Biological Sciences. 2012; 1(4): 20-23.

  • Siddiqui MR, AlOthman ZA, Rahman N. Analytical techniques in pharmaceutical analysis: A review. Arabian Journal of Chemistry, 2017; 10: S1409-S1421.

  • Singh B, Patel DK, Ghosh SK. A reversed-phase high performance liquid chromatographic method for determination of chlorthalidone in pharmaceutical formulation. International Journal of Pharmaceutical Science. 2009; 1(2): 24-9.

  • O'Hare MJ, Tan E, Moody JE. Quantitative determination of chlorthalidone in pharmaceutical dosage forms by high-pressure liquid chromatography. Journal of Pharmaceutical Sciences. 1979; 68 (1): 106-108.

  • Gandhi SV, Sanklecha AP. HPLC method development and validation for estimation of chlorthalidone in tablet dosage form. Journal of Drug Delivery and Therapeutics, 2019; 9 (4): 53-56.

  • Sonawane S, Jadhav S, Rahade P, Chhajed S, Kshirsagar S. Development and validation of stability-indicating method for estimation of chlorthalidone in bulk and tablets with the use of experimental design in forced degradation experiments. Scientifica. Volume 2016, Article ID 4286482, 9 pages.

  • Muthyala NI, Naresh B. Stability indicating RP-HPLC method development and validation for the quantitative estimation chlorthalidone in API and tablet dosage form. International journal of advanced research in Medical and Pharmaceutical Sciences. 2019; 4(10): 32-41.

  • Akshitha MFA. Method validation and development of chlorthalidone by RP-HPLC. International Journal of Advanced Research in Medical and Pharmaceutical Science. Dec.2012; Volume 4, Issue 12: 9-16.

  • Bauer J, Quick J, Krogh S, Shada D. Stability indicating assay for chlorthalidone formulation: Evaluation of the USP analysis and a high performance liquid chromatographic analysis. Journal of Pharmaceutical Sciences. 1983; 72 (8): 924-928.

  • Manikandan S, Thirunarayanan G. Development and validation of reversed phase gradient HPLC method for the simultaneous estimation of olmesartan medoxomil and chlorthalidone in dosage forms. World Scientific News. 2015; (9): 132-154.

  • Youssef RM, Maher HM, El-Kimary EI, Hassan EM, Barary MH. Validated stability-indicating methods for the simultaneous determination of amiloride hydrochloride, atenolol, and chlorthalidone using HPTLC and HPLC with photodiode array detector. Journal of AOAC International. 2013; 96 (2): 313-323.

  • Mhaske RA, Sahasrabudhe S, Mhaske AA. RP-HPLC method for simultataneous determination of irbesartan, losartan, hydrohlorothiazide and chlorthalidone-application to commercially available drug products. International Journal of Pharmaceutical Sciences and Research. 2012; 3 (4): 1116.

  • Sa'Sa' SI, Jalal IM, Khalil HS. Determination of atenolol combinations with hydrochlorothiazide and chlorthalidone in tablet formulations by reverse-phase HPLC. Journal of Liquid Chromatography. 1988; 11 (8): 1673-1696.

  • Sravani P, Rubesh Kumar S, Duganath N, Devanna N. Method development and validation for the simultaneous estimation of azilsartan and chlorthalidone by RP-HPLC in pharmaceutical dosage form. International Journal of Pharmaceutical Science. 2014; 4(5): 725, 729.

  • Dagariya RK, Jat RK. Method development and validation of Irbesartan chlorthalidone and Cilnidipine in their combined tablet dosage form by high performance liquid chromatography. Journal of Drug Delivery and Therapeutics. 2017; 7 (4): 88-96.

  • Solanki VS, Bishnoi RS, Baghel R, Jain D. RP-HPLC method development and validation for simultaneous estimation of cilnidipine, atenolol and chlorthalidone. Journal of Drug Delivery and Therapeutics. 2018; 8 (6-s): 78-82.

  • Dighe NS, Thorat SK, Shinde GS, Dhamak KV. Quantitative estimation and validation of chlorthlidone and azilsartan medoximil in bulk and tablet dosage form by using RP-HPLC. Journal of Drug Delivery and Therapeutics. 2019; 9 (4-s): 264-268.

  • Sawale V, Dangre P, Dhabarde D. I. S. H. A. Development and validation of RP-HPLC method for the simulteneous estimation of olmesartan medoxomil and chlorthalidone in tablet dosage form. International Journal of Pharmacy and Pharmaceutical Sciences. 2015; 7(5): 266-269.

  • Naazneen S, Sridevi A. Stability-indicating RP-HPLC method for the simultaneous estimation of azilsartan medoxomil and chlorthalidone in solid dosage forms. International Journal of Pharmaceutical Science. 2014; 6(6): 236-43.

  • Sharma A, Mishra A, Sharma S. Stability indicating simultaneous validation of telmisartan, cilnidipine and chlorthalidone with forced degradation behavior study by RP-HPLC in tablet dosage form. International Journal of Pharmacy and Pharmaceutical Sciences. 2016; 7: 6-12.

  • Shahana VP, Ramya GM, Rajesh A, Kathirvel S. A comprehensive validation method and development of RP-HPLC for simultaneous estimation of metoprolol, telmisartan and chlorthalidone in bulk and its formulation. Asian Journal of Research in Chemistry. 2018; 11(6): 827-834.

  • Sreelatha P, Reddy DV, Palavai SR, Devi BR. Novel and validated stability-indicating HPLC method for simultaneous estimation of olmisartan and chlorthalidone in oral solid form. American Journal of Pharmatech Research. 2016; 6(3): 333-344.

  • Sherje A, Sonalkar A. Article Details Forced Degradation Studies of Olmesartan medoxomil and Chlorthalidone: Development and Validation of Stability-Indicating RP-HPLC method. Indian Drugs. 2019; 56(3): 39-45.

  • Yunoos M, Sankar DG. Optimization and validation of RP-HPLC stability indicating method for simultaneous determination of olmesartan medoxomil and chlorthalidone in pure drug and pharmaceutical dosage form. Journal of Chemical and Pharmaceutical Research. 2015; 7(3): 2440-2448.

  • Devaka N. V. S. K, Rao VM. Determination of benidipine and chlorthalidone content in tablets using stability-indicating reversephase high-performance liquid chromatography technique. Drug Invention Today. 2020; 13(2).

  • Sawaikar L, Kapupara P. Development and Validation of a Stability indicating RP-HPLC method for the estimation of chlorthalidone and cilnidipine in combined pharmaceutical dosage form. Research Journal of Pharmacy and Technology. 2020; 13(5): 2376-2380.

  • Kalaiselvi P, Lalitha KG. Development and validation of RP-HPLC method for the simultaneous estimation of chlorthalidone and irbesarton in pharmaceutical dosage form. Pharmacophore. 2014; 5 (2): 279-286.

  • Kayesh R, Jahan MS, Sultan MZ. Development using response surface methodology and validation of a stability-indicating RP-HPLC method chlorthalidone in solid dosage form. Chromatographia. 2017; 80 (4): 593-603.

  • Chaudhary BR, Dave JB. Development and validation of stability indicating gradient RP-HPLC method for simultaneous estimation of telmisartan and chlorthalidone in bulk API and fixed dose combination. World Journal of Pharmaceutical Research. 2017; 6(10): 1015-1029.

  • Dangre P, Sawale V, Meshram S, Gunde M. Development and validation of RP-HPLC method for the simultaneous estimation of eprosartan mesylate and chlorthalidone in tablet dosage form. International Journal of PharmTech Research. 2015; 8 (2): 163-168.

  • Kudumula N, Prasad YR. Development and validation of RP-HPLC method for the simultaneous estimation of chlorthalidone and cilnidipine in bulk and combined tablet dosage form. Pharmacophore. 2014; 5 (4): 442-450.

  • Ebeid WM, Elkady EF, El-Zaher AA, El-Bagary RI, Patonay G. Stability-indicating RP-LC method for determination of azilsartan medoxomil and chlorthalidone in pharmaceutical dosage forms: application to degradation kinetics. Analytical and Bioanalytical Chemistry. 2014; 406 (26): 6701-6712.

  • El-Gindy A, Emara S, Mostafa A. HPLC and chemometric-assisted spectrophotometric methods for simultaneous determination of atenolol, amiloride hydrochloride and chlorthalidone. Il Farmaco. 2005; 60 (3): 269-278.

  • Gad MA, Amer SM, Zaazaa HE, Hassan SA. Strategies for stabilizing formulation and QbD assisted development of robust stability indicating method of azilsartan medoxomil/chlorthalidone. Journal of Pharmaceutical and Biomedical Analysis. 2020; 178: 112910.

  • Hinge MA, Bhanusali VM, Mahida RJ. Spectrophotometric and high performance liquid chromatographic determination of chlorthalidone and losartan potassium in combined dosage form. Analytical Chemistry Letters. 2016; 6 (4): 408-420.

  • Mhaske RA, Garole DJ, Mhaske AA, Sahasrabudhe S. RP-HPLC method for simultaneous determination of amlodipine besylate, valsartan, telmisartan, hydrochlorothiazide and chlorthalidone: application to commercially available drug products. International Journal of Pharmaceutical Sciences and Research. 2012; 3 (1): 141.

  • Dave VM, Maheshwari DG. RP-HPLC method for simultaneous estimation of enalapril maleate and chlorthalidone in synthetic mixture. International Journal of Pharmaceutical Sciences Review and Research. 2015; 6 (4): 666-673.

  • Vanaja N, Preethi C, Manjunath SY, Pal K. Method development and validation for simultaneous estimation of telmisartan and chlorthalidone by RP-HPLC in pharmaceutical dosage form. Asian Journal of Pharmaceutical Analysis. 2015; 5 (4): 171-177.

  • Kashyap R. K. R, Srinivasa U. S. U. Development and validation of HPLC method for the simultaneous estimation of chlorthalidone and metoprolol succinate in bulk and dosage form. International Journal of Pharmaceutics and Drug Analysis. 2013; 1(2): 1-14.

  • Jagadeesh K, Annapurna N. Stability indicating method to analyze benidipine and chlorthalidone using HPLC technique: Establishment, validation and application to tablets. Pharmaceutical Sciences. 2020; 26(1): 75-81.

  • Kumar TH, Begum A, Sankar DG. Determination of azilsartan medoximil and chlorthalidone in tablets exposed to forced degradation by using RP-HPLC. Biomedical Research. 2019; 30 (5). 10.35841/biomedicalresearch.30-19-331.

  • Kasimala MB, Kasimala BB. Reverse phase-HPLC method development and validation for the Simultaneous estimation of azilsartan medoxomil and Chlortalidone in pharmaceutical dosage forms. Journal of Atoms and Molecules. 2012; 2(1): 117.

  • Pawar VT, Pawar SV, More HN, Kulkarni AS, Gaikwad DT. RPHPLC method for simultaneous estimation of cilnidipine and chlorthalidone. Research Journal of Pharmacy and Technology. 2017; 10 (11): 3990-3996.

  • Samanthula G, Swain D, Sahu G, Bhagat S, Bharatam PV. Ultra HPLC method for fixed dose combination of azilsartan medoxomil and chlorthalidone: identification and in silico toxicity prediction of degradation products. Journal of Analytical Chemistry. 2018; 73 (6): 560-569.

  • Patel B, Chaudhary A, Gami S. RP-HPLC method development and validation for simultaneous estimation of benidipine hydrochloride, telmisartan and chlorthalidone in Tablet. International Journal of Emerging Technologies and Innovative Research. March 2019, Volume 6, Issue 3: 110-124.

  • Nagaraju K. Analytical method development and validation for the estimation of chlorthalidone and atenolol by RP-HPLC. International Journal for Advance Research and Development. 2018; 3(10): 133- 138.

  • Jyothi AN, Ali SS, Nalluri BN, Unnisa A. Novel RP-HPLC-PDA method for the simultaneous estimation of metoprolol succinate and chlorthalidone in bulk and pharmaceutical dosage forms. Chemical Science Review and Letters. 2014; 3(12): 941-950.

  • Kang HA, Kim HH, Kim SM, Yoon H, Cho HY, Oh SY, Lee YB. Validated HPLC method for the pharmacokinetic study of atenolol and chlorthalidone combination therapy in korean subjects. Journal of Pharmaceutical Investigation. 2006; 36(5): 331-338.

  • Walters SM, Stonys DB. Determination of chlorthalidone and clonidine hydrochloride in tablets by HPLC. Journal of Chromatographic Science. 1983; 21 (1): 43-45.

  • Sheth A, Patel CN, Ramlingam B, Shah N. Simultaneous estimation of metoprolol succinate and chlorthalidone in pharmaceutical solid dosage form by using a developed and validated reverse phase high performance liquid chromatographic technique. Scholars Research Journal. 2012; 2(1):17.

  • Rathod RH, Patil AS, Shirkhedkar AA. Novel NP and RP-HPTLC in praxis for simultaneous estimation of chlorthalidone and cilnidipine in bulk and pharmaceutical formulation. Analytical Chemistry Letters. 2018; 8 (6): 862-871.

  • Joglekar AP. Method development and validation for the estimation of telmisartan and chlorthalidone in bulk and pharmaceutical dosage form by HPTLC Method. Research Journal of Pharmacy and Technology. 2015; 8 (4): 376-381.

  • Parmar KE, Mehta RS, Patel ND, Parmar KE. Development and validation of HPTLC method for simultaneous determination of telmisartan and chlorthalidone in bulk and pharmaceutical dosage form. International Journal of Pharmacy and Pharmaceutical Sciences. 2013; 5 (2): 420-425.

  • Youssef RM, Maher HM, El-Kimary EI, Hassan EM, Barary MH. Validated stability-indicating methods for the simultaneous determination of amiloride hydrochloride, atenolol, and chlorthalidone using HPTLC and HPLC with photodiode array detector. Journal of AOAC International. 2013; 96 (2): 313-323.

  • Tadiboyina S, Bannimath G, Inturi BK. Enantiomeric separation and quantitative estimation of chlorthalidone enantiomers by chiral ultrafast liquid chromatography. International Journal of Research in Pharmacy and Chemistry. 2015; 5: 361-367.

  • Sirisha T, Gurupadayya B, Siddiraju S. Optimized and Validated RPUPLC Method for the Determination of Losartan Potassium and Chlorthalidone in Pharmaceutical Formulations. Advanced Pharmaceutical Bulletin. 2015; 5 (1): 133-136.

  • Singhal M, Amin S, Kukrety A, Chauhan A, Tiwari VK, Singh RM, Singh GN. Development and validation of RP-UPLC method using experimental design approach for simultaneous. Indian Drugs. 2014; 51(11): 33-46.

  • Hussein LA, Magdy NN, Ibrahim MA. Stability-indicating RP-UPLC method for simultaneous determination of azilsartan medoxomil and chlorthalidone in tablets in the presence of its degradation products. Journal of Chromatographic Science. 2019; 57(3): 213-219.


Abstract Views: 186

PDF Views: 0




  • A concise review on analytical profile of chlorthalidone

Abstract Views: 186  |  PDF Views: 0

Authors

Yogesh A. Chaudhari
Department of Pharmaceutics, Smt. S. S. Patil College of Pharmacy, Chopda: 425107, Maharashtra,, India
Vikas R. Patil
Department of Pharmaceutical Chemistry, TSPM’s, Trimurti Institute of Pharmacy, Paldhi (Bk): 425103, Jalgaon, Maharashtra,, India
Rakesh R. Gujar
Department of Pharmaceutics, TSPM’s, Trimurti Institute of Pharmacy, Paldhi (Bk): 425103, Jalgaon, Maharashtra,, India
Kuldip R. Patil
Department of Pharmaceutics, TSPM’s, Trimurti Institute of Pharmacy, Paldhi (Bk): 425103, Jalgaon, Maharashtra,, India
Sopan Nangare
4Department of Pharmaceutical Chemistry, H. R. Patel Institute of Pharmaceutical Education and Research, Shirpur: 425405, Dhule, Maharashtra,, India

Abstract


Chlorthalidone (CHL) is an anti-hypertensive that reduces active sodium reabsorption and peripheral vascular resistance. Also, it is a diuretic commonly known as a thiazide diuretic. Due to the huge amount of use of CHL in different dosage forms for the management of hypertension, it needs qualitative and quantitative estimation in the pharmaceutical and biological formulation. Therefore, the main objective of this analysis of CHL in the pharmaceutical and biological formulation is in both qualitative and quantitative terms. In this review article, we have summarized UV/Vis Spectroscopy, high-performance liquid chromatography (HPLC), High-performance thin-layer chromatography (HPTLC), Ultra performance liquid chromatography (UPLC), etc. based methods for estimation of chlorthalidone. In addition to that, we have discussed the bioanalytical methods for CHL analysis. In conclusion, this review article will help to research scholars for further method development for drug estimation in pharmaceutical dosage forms and biological fluids.

Keywords


Chlorthalidone, Anti-hypertensive, Analytical methods, High-performance liquid chromatography, Bioanalytical methods.

References